IHT Wealth Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

IHT Wealth Management’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-330	Closed	-$21K	–	1558
2018 Q1	$21K	Sell	330 -670	-67%	-$38.7K	0.01%	967
2017 Q4	$51K	Sell	1,000 -9	-0.9%	-$647	0.01%	694
2017 Q3	$86K	Buy	1,009 +9	+0.9%	+$683	0.04%	386
2017 Q2	$30K	Hold	1,000	–	–	0.01%	663
2017 Q1	$51K	Buy	1,000 +500	+100%	+$29.7K	0.03%	415
2016 Q4	$27K	Buy	+500	New	+$26.8K	0.02%	546

Other funds holding ONCE

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

IHT Wealth Management's ONCE Position: Q2 2018 in Review

IHT Wealth Management sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q2 2018, closing a stake of 330 shares — an estimated $21K sold.

IHT Wealth Management first reported a position in ONCE in Q4 2016 and held it in 6 quarters. The position peaked at $86K in Q3 2017. 172 funds tracked by Wall St. Rank hold ONCE as of Q2 2018.

IHT Wealth Management reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
IHT Wealth Management sold 330 Spark Therapeutics, Inc. Common Stock shares in Q2 2018, an estimated $21K.
IHT Wealth Management first reported a position in Spark Therapeutics, Inc. Common Stock in Q4 2016 and held it in 6 quarters.
IHT Wealth Management's Spark Therapeutics, Inc. Common Stock position peaked at $86K in Q3 2017.
172 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q2 2018.

Based on IHT Wealth Management's 13F filing for Q2 2018, filed 13 Aug 2018.